 Athenex Incs NASDAQ: ATNX abstract for subgroup analysis of its Phase 3 study of oral paclitaxel and encequidar Oral Paclitaxel for metastatic breast cancer has been accepted for poster presentation at the 2021 San Antonio Breast Cancer Symposium. The abstract and poster provide data from a post hoc, subgroup analysis of safety, progression-free survival, and overall survival of patients with elevated liver enzymes. 